What do we do?
The Clinigen Group operates across the whole of a medicine’s clinical lifecycle:
from phase I clinical trials to the end of patent and beyond.
Trust us for efficient sourcing and supply of quality products for global clinical trials:
- Commercial medicines
- Comparator, concomitant, rescue and adjuvant medication
- Ancillary medical supplies
- Global storage and distribution
Consult with us to develop bespoke solutions and implement:
- Early Access Programs providing medicines prior to license or launch through Named Patient Programs and Expanded Access Programs
- Commercial Access Programs for post-license medicines
- Mature Product Access Programs continuing to make withdrawn or discontinued drugs available to patients
Partner us when disposing of specialist hospital products, especially those with complex manufacturing and global regulatory requirements. We handle:
- Divestment of late stage, “problematical” assets
- Market withdrawal
- Rationalization strategies